» Articles » PMID: 1685252

Memory Deficits Induced by Gamma-L-glutamyl-L-aspartate and D-2-amino-6-phosphonovalerate in a Y-maze Avoidance Task: Relationship to NMDA Receptor Antagonism

Overview
Specialty Pharmacology
Date 1991 Jan 1
PMID 1685252
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Post-training administration (ICV) of gamma-L-glutamyl-L-aspartate (gamma-LGLA) or D-2-amino-5-phosphonovalerate (D-AP5), a competitive NMDA antagonist, decreased retention of the temporal component but not the spatial discrimination component of a Y-maze active avoidance task. Inverted U-shaped dose-response curves were obtained for the ability of gamma-LGLA and D-AP5 to decrease retention, with maximum effects occurring at doses of 2-20 nmol/mouse for gamma-LGLA and 0.02 nmol/mouse for D-AP5. gamma-LGLA and D-AP5 impaired the traction reflex only at doses (80 and 2 nmol/mouse, respectively) higher than those producing retention deficits. Convulsions induced by ICV administration of 1 nmol NMDA were antagonized by gamma-LGLA and D-AP5 with ED50 values of 46 (32-66) and 0.2 (0.16-0.25) nmol/mouse, respectively. The dose-effect curve of NMDA for producing convulsions was shifted to the right in a parallel manner and to the same extent by 80 nmol gamma-LGLA and by 0.3 nmol D-AP5. Taken together, these results are consistent with previous studies suggesting that the behavioral effects of gamma-LGLA might be related to its NMDA receptor antagonist properties. The selectivity of the memory deficits induced by gamma-LGLA and D-AP5 is in agreement with recent reports suggesting a role for NMDA receptors in the mechanisms underlying posttraining organization of memory traces.

Citing Articles

The inverted "u-shaped" dose-effect relationships in learning and memory: modulation of arousal and consolidation.

Baldi E, Bucherelli C Nonlinearity Biol Toxicol Med. 2009; 3(1):9-21.

PMID: 19330154 PMC: 2657842. DOI: 10.2201/nonlin.003.01.002.


The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task.

Mathis C, Paul S, Crawley J Psychopharmacology (Berl). 1994; 116(2):201-6.

PMID: 7862949 DOI: 10.1007/BF02245063.

References
1.
Ungerer A, Mathis C, Melan C, De Barry J . The NMDA receptor antagonists, CPP and gamma-L-glutamyl-L-aspartate, selectively block post-training improvement of performance in a Y-maze avoidance learning task. Brain Res. 1991; 549(1):59-65. DOI: 10.1016/0006-8993(91)90599-q. View

2.
Lehmann J, Hutchison A, McPherson S, Mondadori C, Schmutz M, Sinton C . CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist. J Pharmacol Exp Ther. 1988; 246(1):65-75. View

3.
Kleinschmidt A, Bear M, Singer W . Blockade of "NMDA" receptors disrupts experience-dependent plasticity of kitten striate cortex. Science. 1987; 238(4825):355-8. DOI: 10.1126/science.2443978. View

4.
DeNoble V, Jones K, Schaeffer C, Bauerle L . 3-((+-)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) and phencyclidine produce a deficit of passive avoidance retention in rats. Eur J Pharmacol. 1990; 175(2):197-202. DOI: 10.1016/0014-2999(90)90230-4. View

5.
ONeill K, Liebman J . Unique behavioral effects of the NMDA antagonist, CPP, upon injection into the medial pre-frontal cortex of rats. Brain Res. 1987; 435(1-2):371-6. DOI: 10.1016/0006-8993(87)91628-3. View